[48] developed panels targeting patient-specific KIT and PDGFRa mutations in GIST patients, termed “simple multiplexed PCR-based barcoding of DNA for sensitive mutation detection using sequencing” (SiMSen-Seq). The gene discussed is PDGFRA; the disease is gastrointestinal stromal tumor.